Researchers have developed nanowires that can record the electrical activity of neurons in fine detail. The technology will allow for better investigation as to how the brain works.
Using animal models, researchers demonstrate a potentially effective approach to treating blindness associated with genetic conditions by using mRNA and lipid nanoparticles.
Researchers have developed drug-carrying nanoparticles that cross the blood-brain barrier, allowing for more effective delivery to the brain than conventional medications. The nanoparticles can get into tumors and kill glioblastoma brain cancer cells.
Researchers report shorter nanowires would be a better option for implanting into the brain.
Researchers have use nanotechnology to develop a 1:1 scale model of the blood-brain barrier.
Researchers have developed a method of fabricating nanoscale electronic scaffolds that can be injected. The scaffolds can be used to monitor neural activity or promote neurogenesis.
Newly designed microbots can deliver vital drugs throughout the human body. The microbots can traverse the body and penetrate bodily mucus to efficiently deliver medications to target sites.
An international team of researchers have created remote controlled nanobots from a biodegradable material that they believe could assist doctors in diagnosing diseases and delivering drugs to target sites.
A new nanocarrier meets the size and stability to effectively pass the BBB and deliver drugs to glioblastoma multiforme brain cancer.
Researchers have developed a new approach to prevent amyloid plaque formation by engineering a nanodevice that captures the peptides before they can assemble. The silica nanodevice might be a new tool in the treatment and prevention of Alzheimer's disease and other neurodegenerative diseases associated with amyloid-beta.
A new nanoparticle drug-delivery system resulted in unprecedented siRNA penetration across the intact blood-brain barrier. Researchers say the system could help doctors to treat secondary injuries associated with TBI that can result in Alzheimer's and other neurodegenerative disorders.
Amyloid plaques can cling to newly developed bowl-shaped nanoparticles. The findings provide a new way to study the Alzheimer's related plaques and provides novel treatment options for dementia.
